GLP-1 RECEPTOR AGONISTS AND COLORECTAL CANCER: BIOLOGICAL PLAUSIBILITY AND CURRENT EVIDENCE. IJITSS. 2026;1(1(49). doi:10.31435/ijitss.1(49).2026.4822